ALKS - Alkermes Plc - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALKS is currently covered by 13 analysts with an average price target of $34.94. This is a potential upside of $5.85 (20.11%) from yesterday's end of day stock price of $29.09.

Alkermes Plc's activity chart (see below) currently has 309 price targets and 234 ratings on display. The stock rating distribution of ALKS is 39.02% HOLD, 56.1% BUY and 4.88% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.57% with an average time for these price targets to be met of 228.27 days.

Highest price target for ALKS is $46, Lowest price target is $26, average price target is $36.45.

Most recent stock forecast was given by ASHWANI VERMA from UBS on 17-Jun-2025. First documented stock forecast 17-Oct-2013.

Split History since 2000:

5/15/00 2 for 1

Currently out of the existing stock ratings of ALKS, 16 are a HOLD (39.02%), 23 are a BUY (56.1%), 2 are a SELL (4.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$42

$12.91 (44.38%)

$38

4 days ago
(17-Jun-2025)

2/4 (50%)

$12.23 (41.08%)

86

Buy

$32

$2.91 (10.00%)

$30

4 months 7 days ago
(14-Feb-2025)

13/18 (72.22%)

$-3.89 (-10.84%)

631

Hold

$46

$16.91 (58.13%)

$37

4 months 8 days ago
(13-Feb-2025)

19/23 (82.61%)

$10 (27.78%)

295

Buy

$40

$10.91 (37.50%)

$35

7 months 8 days ago
(13-Nov-2024)

4/6 (66.67%)

$10.76 (36.80%)

699

Buy

$36

$6.91 (23.75%)

$25

7 months 16 days ago
(05-Nov-2024)

20/27 (74.07%)

$7.63 (26.89%)

141

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALKS (Alkermes Plc) average time for price targets to be met?

On average it took 228.27 days on average for the stock forecasts to be realized with a an average price target met ratio 73.57

Which analyst has the current highest performing score on ALKS (Alkermes Plc) with a proven track record?

MICHAEL SCHMIDT

Which analyst has the most public recommendations on ALKS (Alkermes Plc)?

Michael Schmidt works at GUGGENHEIM and has 5 price targets and 3 ratings on ALKS

Which analyst is the currently most bullish on ALKS (Alkermes Plc)?

Jonathan Eckard with highest potential upside - $36.91

Which analyst is the currently most reserved on ALKS (Alkermes Plc)?

Terence Flynn with lowest potential downside - -$13.09

Alkermes Plc in the News

Alkermes' Q1 Earnings and Revenues Fall Short of Estimates

Alkermes plc ALKS reported earnings from continuing operations of 13 cents per share for first-quarter 2025, which missed the Zacks Consensus Estimate of 28 cents. The company had reported earnings of 21 cents per share in the year-ago quarter. Alkermes’ total revenues of $306.5 million in the first quarter decreased 12.5% from the year-ago quarter’s...

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ...

Total Revenue: $306.5 million for Q1 2025. Net Sales from Proprietary Products: $244.5 million, reflecting 5% year-over-year growth. Vivitrol Net Sales: $101 million for Q1 2025. Aristada Net Sales: $73.5 million for Q1 2025. Lybalvi Net Sales: $70 million, with 23% year-over-year growth. Manufacturing and Royalty Revenues: $62 million for Q1 2025. Cost of Goods...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?